← Back to Search

Tai Chi for Multiple Myeloma

N/A
Waitlist Available
Led By Krisstina Gowin, DO
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Multiple Myeloma planned to undergo bone marrow transplant
18 years or older
Must not have
Grade 3 or greater neuropathy
Concurrent major depressive disorder or anxiety disorder (DSMIV)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 100
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if Tai Chi Easy can help improve immune function and quality of life in multiple myeloma patients who are undergoing stem cell transplants.

Who is the study for?
This trial is for English-speaking adults over 18 with Multiple Myeloma who are about to have a bone marrow transplant and can do basic physical activities (ECOG status 0-1). They must be able to attend Tai Chi sessions. People with recent fainting, severe depression or anxiety, regular Tai Chi/Qi Gong/Yoga practice, chronic dizziness, frequent falls, or serious neuropathy cannot join.
What is being tested?
The TOTOM Trial is testing whether practicing Tai Chi Easy can improve immune function and quality of life in patients undergoing stem cell transplants for Multiple Myeloma. Participants will attend designated Tai Chi training sessions as part of the study.
What are the potential side effects?
Tai Chi Easy is generally considered safe but may include risks like muscle soreness or strain. Since it's a gentle form of exercise, serious side effects are not common.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have Multiple Myeloma and am planning to have a bone marrow transplant.
Select...
I am 18 years old or older.
Select...
I am fully active or can carry out light work.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe nerve pain or damage.
Select...
I have been diagnosed with major depression or an anxiety disorder.
Select...
I have fainted in the last 60 days.
Select...
I suffer from long-term dizziness or balance problems.
Select...
I have fallen more than twice in the last year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 100
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 100 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Determine NK cell activity
Determine immune function
Determine natural killer cell phenotype

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tai Chi Easy InterventionExperimental Treatment1 Intervention
Tai Chi Easy: TCE is a standardized protocol used in several prior studies. TCE has been manualized and has a formal training program for instructors. The protocol is taught as a series of repeated and simple-to-learn movements. Patients will receive two 30-minute small group training sessions (Via Zoom) within 7 days of their scheduled transplant. After the training has been completed the participant will be provided with written (via manual) and electronic (DVD, MP3 file download) materials to continue with self-direct practice throughout the duration of the study.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Multiple Myeloma include chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation. Chemotherapy works by killing rapidly dividing cancer cells, while immunotherapy boosts the body's immune system to better recognize and attack cancer cells. Targeted therapies specifically inhibit the growth and survival pathways of myeloma cells. Stem cell transplantation replaces diseased bone marrow with healthy stem cells to restore normal blood cell production. These treatments are crucial for managing Multiple Myeloma as they help control disease progression, alleviate symptoms, and improve survival rates. Additionally, interventions like Tai Chi Easy, which focus on stress reduction and physical activity, may enhance immune function and health-related quality of life, providing a complementary approach to traditional treatments.
Feasibility of Aerobic Exercise and Tai-Chi Interventions in Advanced Lung Cancer Patients: A Randomized Controlled Trial.People With Hematological Malignancies Treated With Bone Marrow Transplantation Have Improved Function, Quality of Life, and Fatigue Following Exercise Intervention: A Systematic Review and Meta-Analysis.Exercise for physical fitness, fatigue and quality of life of patients undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
536 Previous Clinical Trials
159,685 Total Patients Enrolled
7 Trials studying Multiple Myeloma
839 Patients Enrolled for Multiple Myeloma
Krisstina Gowin, DOPrincipal InvestigatorUniversity of Arizona
Kristinna Gowin, DOPrincipal InvestigatorUniversity of Arizona

Media Library

Tai Chi Easy Clinical Trial Eligibility Overview. Trial Name: NCT04760405 — N/A
Multiple Myeloma Research Study Groups: Tai Chi Easy Intervention
Multiple Myeloma Clinical Trial 2023: Tai Chi Easy Highlights & Side Effects. Trial Name: NCT04760405 — N/A
Tai Chi Easy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04760405 — N/A
~3 spots leftby Dec 2025